Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:pyrrolopyrazine
go back to main search page
Accession:CHEBI:48337 term browser browse the term
Synonyms:related_synonym: pyrrolopyrazines


show annotations for term's descendants       view all columns           Sort by:
 
zopiclone term browser
Symbol Object Name JBrowse Chr Start Stop Reference
G Cyp2c79 cytochrome P450, family 2, subfamily c, polypeptide 79 JBrowse link 1 147,236,480 147,307,988 RGD:6480464

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19770
    chemical entity 19769
      atom 19768
        nonmetal atom 19641
          nitrogen atom 18449
            nitrogen molecular entity 18449
              organonitrogen compound 18249
                organonitrogen heterocyclic compound 17217
                  pyrrolopyrazine 1
                    (6S,8aS)-2-(benzylsulfonyl)-N-\{[1-(N'-hydroxycarbamimidoyl)piperidin-4-yl]methyl\}-4-oxooctahydropyrrolo[1,2-a]pyrazine-6-carboxamide 0
                    (8aS)-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione 0
                    (S)-3-(indol-3-ylmethyl)-6,7,8,8a-tetrahydropyrrolo[1,2-a]pyrazin-1-one 0
                    (S)-3-\{[2-(1,1-dimethylallyl)-indol-3-yl]methyl\}-6,7,8,8a-tetrahydropyrrolo[1,2-a]pyrazin-1-one 0
                    1-hydroxy-3-(indol-3-ylmethyl)-6H,7H,8H-5lambda(5)-pyrrolo[1,2-a]pyrazin-5-ylium 0
                    1-hydroxy-3-\{[2-(1,1-dimethylallyl)-indol-3-yl]methyl\}-4H,6H,7H,8H-pyrrolo[1,2-a]pyrazin-2-ium 0
                    1-hydroxy-3-\{[2-(1,1-dimethylallyl)-indol-3-yl]methyl\}-6H,7H,8H-5lambda(5)-pyrrolo[1,2-a]pyrazin-5-ylium 0
                    18-oxotryprostatin A 0
                    2-\{3-[(3S,8aS)-1,4-dioxooctahydropyrrolo[1,2-a]pyrazin-3-yl]propyl\}guanidine 0
                    4-(7-butyl-5H-pyrrolo[2,3-b]pyrazin-6-yl)phenol 0
                    6-hydroxydeoxybrevianamide E 0
                    6-hydroxytryprostatin B 0
                    brevianamide F + 0
                    butyl (2S,3S)-3-(trans-4-aminocyclohexyl)-3-(\{[2-(benzylsulfonyl)-4-oxo-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazin-6-yl]carbonyl\}amino)-2-hydroxypropanoate 0
                    cordysinin A 0
                    cyclo(L-His-L-Pro) 0
                    cyclo(L-Leu-L-Pro) 0
                    deoxybrevianamide E 0
                    maculosin 0
                    notoamide C 0
                    notoamide E 0
                    notoamide S + 0
                    tryprostatin A 0
                    tryprostatin B 0
                    zopiclone + 1
Path 2
Term Annotations click to browse term
  CHEBI ontology 19770
    subatomic particle 19768
      composite particle 19768
        hadron 19768
          baryon 19768
            nucleon 19768
              atomic nucleus 19768
                atom 19768
                  main group element atom 19653
                    p-block element atom 19653
                      p-block molecular entity 19653
                        carbon group molecular entity 19548
                          organic molecular entity 19537
                            organic molecule 19456
                              organic cyclic compound 19213
                                organic heterocyclic compound 18293
                                  organic heteropolycyclic compound 17588
                                    organic heterobicyclic compound 16253
                                      pyrrolopyrazine 1
                                        (6S,8aS)-2-(benzylsulfonyl)-N-\{[1-(N'-hydroxycarbamimidoyl)piperidin-4-yl]methyl\}-4-oxooctahydropyrrolo[1,2-a]pyrazine-6-carboxamide 0
                                        (8aS)-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione 0
                                        (S)-3-(indol-3-ylmethyl)-6,7,8,8a-tetrahydropyrrolo[1,2-a]pyrazin-1-one 0
                                        (S)-3-\{[2-(1,1-dimethylallyl)-indol-3-yl]methyl\}-6,7,8,8a-tetrahydropyrrolo[1,2-a]pyrazin-1-one 0
                                        1-hydroxy-3-(indol-3-ylmethyl)-6H,7H,8H-5lambda(5)-pyrrolo[1,2-a]pyrazin-5-ylium 0
                                        1-hydroxy-3-\{[2-(1,1-dimethylallyl)-indol-3-yl]methyl\}-4H,6H,7H,8H-pyrrolo[1,2-a]pyrazin-2-ium 0
                                        1-hydroxy-3-\{[2-(1,1-dimethylallyl)-indol-3-yl]methyl\}-6H,7H,8H-5lambda(5)-pyrrolo[1,2-a]pyrazin-5-ylium 0
                                        18-oxotryprostatin A 0
                                        2-\{3-[(3S,8aS)-1,4-dioxooctahydropyrrolo[1,2-a]pyrazin-3-yl]propyl\}guanidine 0
                                        4-(7-butyl-5H-pyrrolo[2,3-b]pyrazin-6-yl)phenol 0
                                        6-hydroxydeoxybrevianamide E 0
                                        6-hydroxytryprostatin B 0
                                        brevianamide F + 0
                                        butyl (2S,3S)-3-(trans-4-aminocyclohexyl)-3-(\{[2-(benzylsulfonyl)-4-oxo-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazin-6-yl]carbonyl\}amino)-2-hydroxypropanoate 0
                                        cordysinin A 0
                                        cyclo(L-His-L-Pro) 0
                                        cyclo(L-Leu-L-Pro) 0
                                        deoxybrevianamide E 0
                                        maculosin 0
                                        notoamide C 0
                                        notoamide E 0
                                        notoamide S + 0
                                        tryprostatin A 0
                                        tryprostatin B 0
                                        zopiclone + 1
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.